Your browser doesn't support javascript.
loading
Cross-protection study of a Mannheimia haemolytica serotype 1 vaccine against acute pasteurellosis in lambs induced by a serotype 2 strain.
Zheng, Tao; Gupta, Sandeep K; McCarthy, Allison R; Moffat, John; Buddle, Bryce M.
Afiliação
  • Zheng T; AgResearch Limited, Hopkirk Research Institute, Grasslands Research Centre, Private Bag 11008, Palmerston North 4442, New Zealand. Electronic address: tao.zheng@agresearch.co.nz.
  • Gupta SK; AgResearch Limited, Hopkirk Research Institute, Grasslands Research Centre, Private Bag 11008, Palmerston North 4442, New Zealand.
  • McCarthy AR; AgResearch Limited, Hopkirk Research Institute, Grasslands Research Centre, Private Bag 11008, Palmerston North 4442, New Zealand.
  • Moffat J; MSD Animal Health Limited, Merck Animal Health, 33 Whakatiki Street, Upper Hutt, Wellington, New Zealand.
  • Buddle BM; AgResearch Limited, Hopkirk Research Institute, Grasslands Research Centre, Private Bag 11008, Palmerston North 4442, New Zealand.
Vet Microbiol ; 177(3-4): 386-93, 2015 Jun 12.
Article em En | MEDLINE | ID: mdl-25843945
ABSTRACT
Ovine pneumonia is an economic important disease worldwide for the sheep industry. Multiple serotypes (S) of Mannheimia haemolytica are involved in the disease and S2 and S1 are the most frequent isolates associated with lung lesions in sheep. Vaccines based on some M. haemolytica S2 strains have been shown to have poor immunogenicity. The objective of this study was to determine the cross-protection effect of an S1 strain based vaccine, Bovilis MH, in sheep against an experimental challenge with an S2 strain. Lambs (n=12) in the vaccine group were injected subcutaneously with 1 ml of the Bovilis MH vaccine, and revaccinated 4 weeks later, while the control group (n=12) received 1 ml of saline at each occasion. Two weeks after revaccination, all lambs were challenged intratracheally with parainfluenza virus 3, and with an M. haemolytica S2 strain at day 7 post-viral challenge. The proportion of animals having pyrexia in the first 2 days post-bacterial challenge was significantly less in the vaccine group compared to the control group (P<0.05). The animals in the vaccine group had significantly lower dyspnoea scores and lung/bodyweight ratio than those in the control group (P<0.05). The vaccine provided 49.1% overall protection. Prior to the challenge, the vaccinated animals had significantly higher titres of antibodies to S1 and S2 whole cell antigens and to leukotoxins produced by S1 and S2 strains compared to the control animals (P<0.05). The S1 strain vaccine provided considerable cross-protection against the S2 strain challenge.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças dos Ovinos / Vacinas Bacterianas / Pasteurelose Pneumônica / Mannheimia haemolytica Limite: Animals Idioma: En Revista: Vet Microbiol Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças dos Ovinos / Vacinas Bacterianas / Pasteurelose Pneumônica / Mannheimia haemolytica Limite: Animals Idioma: En Revista: Vet Microbiol Ano de publicação: 2015 Tipo de documento: Article